Fall Savings30% off everything · Code:
Back
Peptide

KPV

CAS 67727-97-3Research Use Only

The C-terminal tripeptide of alpha-MSH (Lys-Pro-Val), studied in the literature for its role in melanocortin-derived inflammatory-signaling pathways. For laboratory research use only.

$50$35WITH CODE FALL
Quantity
$50.00
Bundle & save
Free priority shipping on $250+
Third-party tested
U.S.-synthesized & shipped
Discreet packaging
Secure checkoutVisaMastercardAmerican ExpressDiscover

Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.

Compound Information

Technical specifications

Molecular Profile

What is this compound?

KPV is the C-terminal tripeptide fragment (11-13) of alpha-melanocyte-stimulating hormone, supplied as a lyophilized powder for in vitro laboratory research use only. It is characterized in the peer-reviewed literature as a melanocortin-derived peptide investigated in research models of inflammatory signaling, epithelial barrier research, and mucosal biology.

Research applications: Commonly used in melanocortin signaling studies, inflammatory-pathway research, and epithelial research applications.

Type
alpha-MSH (11-13) C-terminal tripeptide
CAS Number
67727-97-3
Molecular Weight
342.43 g/mol
Formula
C16H30N4O4
Amino Acids
3
Sequence
Lys-Pro-Val
PubChem Database
Storage Requirements

Stability Information

Protect from lightTemperature-sensitive
Lyophilized (powder)-20°C · stable long-term
Reconstituted2-8°C · use within 28 days

Sources & References

Peer-reviewed research

Inflammatory bowel diseases
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
2008PMID 18092346DOI 10.1002/ibd.20334
Kannengiesser K, Maaser C, Heidemann J, et al.
View on PubMed
The Journal of investigative dermatology
alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells
2004PMID 15102092DOI 10.1111/j.0022-202X.2004.22404.x
Elliott RJ, Szabo M, Wagner MJ, et al.
View on PubMed
Molecular therapy : the journal of the American Society of Gene Therapy
2017PMID 28143741DOI 10.1016/j.ymthe.2016.11.020
Xiao B, Xu Z, Viennois E, et al.
View on PubMed

Some titles are not reproduced here. Ventra Sciences sells for research use only and does not republish therapeutic indications; open the record on PubMed to read the full citation.

References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.

For research use only

This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.

By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.

Subscribe to our newsletter

Exclusive updates and restock alerts, straight to your inbox.